Paydirt
HP
Insider

Henry E. Pelish

Chief Scientific Officer

Henry E. Pelish (Chief Scientific Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.3M of NUVL (33,994 sh across 4 lots, as filed), executed Mar 12.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.1M
shares × price, as filed
Last traded
Jul 9
Filed Jul 10

Median ADV $288.8M across their filed names

Open performance
Volume by month
$3.3M$1.7M$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $108KJun 2025 · sells $863KJul 2025 · sells $578KAug 2025 · sells $412KSep 2025 · sells $294KOct 2025 · sells $2.0MJan 2026 · sells $352KMar 2026 · sells $3.3MApr 2026 · sells $229KJul 2026 · sells $261K
Buys $0 Sells $8.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names
NUVL Nuvalent Inc NUVL · 0 buys · 11 sells 11 filings
Recent filings
NUVLSALE Nuvalent Inc View filing → $578K
7,205 sh across 2 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET
NUVLSALE Nuvalent Inc View filing → $863K
10,800 sh across 2 lots
Exec Jun 25 2025
Filed Jun 27 2025 · 5:30 PM ET
NUVLSALE Nuvalent Inc View filing → $108K
1,343 sh × $80.54
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET
NUVLSALE Nuvalent Inc View filing → $3.2M
31,989 sh across 8 lots
Exec Sep 16 2024
Filed Sep 18 2024 · 5:30 PM ET